Dopamine and Cognition

TW Robbins
DOI: https://doi.org/10.1097/00019052-200312002-00001
2003-01-01
Current Opinion in Neurology
Abstract:© 2003 Lippincott Williams & Wilkins 1350-7540 Editorial review The mapping of the central dopamine pathways into mesostriatal, mesolimbic and mesocortical systems, the cloning of the main dopamine receptors and the identification and characterization of their cell signalling pathways, have all raised important questions about the functions of this important neuromodulatory neurotransmitter [1]. The involvement of dopamine in Parkinson’s disease has focused attention on the apparent motor functions of this neurotransmitter in regulating the output of the striatum, but discoveries that fluctuations in mesolimbic dopamine subserve the reinforcing effects of many drugs of abuse, especially the psychomotor stimulants amphetamine and cocaine, also indicate parallel roles for dopamine in motivational as well as motor, functions. More recently, electrophysiological studies of single units in monkeys exhibiting burst firing patterns in certain conditioning contexts [2] have implicated these same dopamine neurons in error prediction for reinforcement learning. However, burgeoning evidence of a role for dopamine in aspects of frontal lobe function, such as working memory, suggests an even closer and more direct relationship to cognition. A now classic study by the late Patricia Goldman-Rakic and colleagues [3] indicated that dopamine depletion from the sulcus principalis of the monkey prefrontal cortex specifically impaired spatial working memory, as measured in the delayed response task. Moreover, these deficits were remediated by drugs such as L-dopa and apomorphine, thus opening up a new era of potential therapeutic approaches in treating the cognitive deficits in such neurological and neuropsychiatric disorders as Parkinson’s disease, attention deficit hyperactivity disorder, schizophrenia and phenylketonuria.
What problem does this paper attempt to address?